nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—NISCH—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.175	0.175	CbGpPWpGaD
Phentolamine—ADRA1D—Monoamine GPCRs—DRD4—conduct disorder	0.03	0.03	CbGpPWpGaD
Phentolamine—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0271	0.0271	CbGpPWpGaD
Phentolamine—ADRA2C—Monoamine GPCRs—DRD4—conduct disorder	0.0253	0.0253	CbGpPWpGaD
Phentolamine—ADRA1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.0252	0.0252	CbGpPWpGaD
Phentolamine—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0249	0.0249	CbGpPWpGaD
Phentolamine—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0227	0.0227	CbGpPWpGaD
Phentolamine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0221	0.0221	CbGpPWpGaD
Phentolamine—ADRA2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0212	0.0212	CbGpPWpGaD
Phentolamine—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0209	0.0209	CbGpPWpGaD
Phentolamine—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Phentolamine—ADRA1D—Monoamine GPCRs—HTR2A—conduct disorder	0.0196	0.0196	CbGpPWpGaD
Phentolamine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0186	0.0186	CbGpPWpGaD
Phentolamine—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Phentolamine—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Phentolamine—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0165	0.0165	CbGpPWpGaD
Phentolamine—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0164	0.0164	CbGpPWpGaD
Phentolamine—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0162	0.0162	CbGpPWpGaD
Phentolamine—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Phentolamine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Phentolamine—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0139	0.0139	CbGpPWpGaD
Phentolamine—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0136	0.0136	CbGpPWpGaD
Phentolamine—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Phentolamine—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Phentolamine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0121	0.0121	CbGpPWpGaD
Phentolamine—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00885	0.00885	CbGpPWpGaD
Phentolamine—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.00868	0.00868	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00799	0.00799	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00746	0.00746	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00734	0.00734	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00674	0.00674	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00652	0.00652	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00608	0.00608	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00606	0.00606	CbGpPWpGaD
Phentolamine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00578	0.00578	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00568	0.00568	CbGpPWpGaD
Phentolamine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00563	0.00563	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00559	0.00559	CbGpPWpGaD
Phentolamine—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00526	0.00526	CbGpPWpGaD
Phentolamine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00522	0.00522	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00497	0.00497	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00495	0.00495	CbGpPWpGaD
Phentolamine—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00488	0.00488	CbGpPWpGaD
Phentolamine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00488	0.00488	CbGpPWpGaD
Phentolamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00461	0.00461	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00437	0.00437	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Phentolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00418	0.00418	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Phentolamine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00405	0.00405	CbGpPWpGaD
Phentolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00396	0.00396	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Phentolamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00377	0.00377	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00377	0.00377	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00365	0.00365	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00362	0.00362	CbGpPWpGaD
Phentolamine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00344	0.00344	CbGpPWpGaD
Phentolamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00321	0.00321	CbGpPWpGaD
Phentolamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Phentolamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00313	0.00313	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00313	0.00313	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00281	0.00281	CbGpPWpGaD
Phentolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00268	0.00268	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00261	0.00261	CbGpPWpGaD
Phentolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00246	0.00246	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00222	0.00222	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CGA—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00192	0.00192	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.00184	0.00184	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00181	0.00181	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.0018	0.0018	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.00172	0.00172	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.0017	0.0017	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CGA—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00157	0.00157	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.00139	0.00139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.00121	0.00121	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—EP300—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—EP300—conduct disorder	0.000984	0.000984	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000965	0.000965	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000953	0.000953	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000949	0.000949	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000931	0.000931	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—COMT—conduct disorder	0.00093	0.00093	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MAOA—conduct disorder	0.000923	0.000923	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000865	0.000865	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000843	0.000843	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—EP300—conduct disorder	0.000799	0.000799	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000783	0.000783	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—COMT—conduct disorder	0.000755	0.000755	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MAOA—conduct disorder	0.00075	0.00075	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000746	0.000746	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000674	0.000674	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000629	0.000629	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000619	0.000619	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.00055	0.00055	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000511	0.000511	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—EP300—conduct disorder	0.000399	0.000399	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000395	0.000395	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000357	0.000357	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000333	0.000333	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000328	0.000328	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—EP300—conduct disorder	0.000324	0.000324	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000291	0.000291	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000271	0.000271	CbGpPWpGaD
